Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05343390
Other study ID # 20-1810
Secondary ID R01MH124526
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2021
Est. completion date November 30, 2023

Study information

Verified date April 2024
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Having health workers assist HIV-infected persons with the recruitment and testing of their sexual contacts and biological children is an effective and efficient way of identifying additional HIV-infected persons in need of HIV treatment and HIV-uninfected persons in need of HIV prevention. However, in Malawi, a country with a generalized HIV epidemic, health workers lack the counseling and coordination skills to routinely assist their HIV-infected clients with these services. This study will determine how to help health workers to effectively and efficiently provide these services to their patients through a set of digital capacity-building tools.


Description:

Voluntary assisted contact tracing (ACT) is an evidence-based approach that efficiently identifies persons in need of HIV treatment and prevention. Malawi, like many countries in sub-Saharan Africa, has adopted ACT policies to support its "95-95-95" targets for HIV testing, treatment, and viral suppression. However, Malawi's ACT implementation has been poor due to deficits in health worker capacity and clinical coordination. Through preliminary work, our team has 1) developed a set of implementation strategies (theory-based health worker training and continuous quality improvement processes) that address these barriers; 2) packaged these strategies into a blended learning platform that combines digital and face-to-face modalities; and 3) field-tested the package in Malawi with promising preliminary results. In this proposal, the package will be rigorously evaluated in Malawi for implementation, service uptake, and cost-effectiveness outcomes. Through a two-arm pragmatic cluster randomized implementation trial, the proposed research will address these gaps through three specific aims. Twenty Malawian facilities in two districts will be randomized to receive the blended learning implementation package (enhanced) versus standard implementation package (standard). In the first aim, ACT implementation outcomes will be compared between the enhanced and standard arms. Health worker fidelity to ACT procedures will be assessed through audio-recorded ACT encounters. In the second aim, HIV service uptake outcomes will be compared between the enhanced and standard arms. In the third aim, cost and cost-effectiveness outcomes will be examined. The findings will offer important insights and innovations into how to bridge the gap between ACT research and practice, a critical step towards achieving the 95-95-95 targets.


Recruitment information / eligibility

Status Completed
Enrollment 841
Est. completion date November 30, 2023
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years and older
Eligibility Health worker inclusion criteria: - 18 years of age or older - working full-time at one of the health facilities included in the study - staff in Malawi's Assisted Contact Tracing program. Health worker exclusion criteria: - conditions that would compromise ability of participant to provide informed consent, undergo study procedures safely, or prevent proper conduct of study Patient (index or contact) inclusion criteria: ->=15 years -potential index, contact, or parent or guardian of a potential index or contact Patient (index or contact) exclusion criteria: - conditions that would compromise ability of individual to provide informed consent, undergo study procedures safely, or prevent proper conduct of study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Enhanced implementation package
Individual training with teaching and modeling (tablet-guided, ~8 hours) Small group training with practice and feedback (tablet-guided, ~16 hours) Ongoing continuous quality improvement sessions (tablet-guided, ~2 hours/month)
Standard implementation package
Individual training with teaching (facilitator-guided, ~2 hours) Small group practice (facilitator-guided, ~1 hour) Ongoing clinic support (facilitator-guided, ~30 minutes/month)

Locations

Country Name City State
Malawi Balaka District Hospital Balaka
Malawi Balaka OPD Health Centre Balaka
Malawi Chiendausiku Health Centre Balaka
Malawi Kalembo Health Centre Balaka
Malawi Kankao Health Centre Balaka
Malawi Kwitanda Health Centre Balaka
Malawi Mbera Health Centre Balaka
Malawi Namanolo Health Centre Balaka
Malawi Namdumbo Health Centre Balaka
Malawi Phalula Health Centre Balaka
Malawi Phimbi Health Centre Balaka
Malawi Ulongwe Health Centre Balaka
Malawi Utale Health Centres Balaka
Malawi Chamba Dispensary Machinga
Malawi Chikweo Health Centre Machinga
Malawi Gawanani Health Centre Machinga
Malawi Kawinga Dispensary Machinga
Malawi Machinga District Hospital Machinga
Malawi Mahinga Health Centre Machinga
Malawi Mangamba Health Centre Machinga
Malawi Mbonechela Dispensary Machinga
Malawi Mkwepere Health Centre Machinga
Malawi Mpiri Health Centre Machinga
Malawi Mposa Health Centre Machinga
Malawi Namandanje Health Centre Machinga
Malawi Namanja Health Centre Machinga
Malawi Nayinunje Health Centre Machinga
Malawi Nayuchi Health Centre Machinga
Malawi Ngokwe health Centre Machinga
Malawi Nsanama Health Centre Machinga
Malawi Ntaja Health Centre Machinga
Malawi Nthorowa Health Centre Machinga
Malawi Nyambi Health Centre Machinga

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

Malawi, 

Outcome

Type Measure Description Time frame Safety issue
Primary Index client fidelity assessment Health care workers will be observed counseling actual index clients. The scores on the 15-item index client fidelity assessment will be compared between arms (range 0-100% with higher scores being better) 1 year after training
Primary Contact client fidelity assessment Health care workers will be observed counseling actual contact clients. The scores on the 15-item contact client fidelity assessment will be compared between arms (range 0-100% with higher scores being better) 1 year after training
Primary Index clients who participate in assisted contact tracing The total number of index clients who participate in assisted contact tracing relative to the number of total potential index clients measured per facility per calendar quarter (3-month period) 1 year after training
Primary Contact clients elicited The number of contact clients listed by participating index clients relative to the number of total potential index clients measured per facility per calendar quarter (3-month period) 1 year after training
Primary HIV self-test kits distributed The number of HIV self-test kits distributed relative to the number of total potential index clients measured per facility per calendar quarter (3-month period) 1 year after training
Primary Contact clients tested The number of contact clients tested relative to the number of total potential index clients measured per facility per calendar quarter (3-month period) 1 year after training
Primary Contact clients living with HIV identified The number of contact clients living with HIV identified relative to the number of total potential index clients measured per facility per calendar quarter (3-month period) 1 year after training
Primary Cost per contact tested The incremental cost per contact tested 1 year after training
Primary Cost per person living with HIV diagnosed The incremental cost per person living with HIV identified 1 year after training
See also
  Status Clinical Trial Phase
Terminated NCT03516318 - Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria N/A
Completed NCT04653194 - Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat' Phase 3
Completed NCT01792570 - DRV/r + RPV QD: Efficacy and Toxicity Reduction Phase 3
Active, not recruiting NCT04826562 - Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND) Phase 4
Completed NCT04191967 - Thermocoagulation for Treatment of Precancerous Cervical Lesions N/A
Completed NCT02812329 - Intervention to Encourage HIV Testing and Counseling Among Adolescents Phase 1
Completed NCT02919306 - Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults Phase 1/Phase 2
Completed NCT02516930 - A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in China N/A
Completed NCT02651376 - Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients Phase 1/Phase 2
Recruiting NCT02392884 - HIV Medication Adherence in Underserved Populations N/A
Completed NCT01944371 - Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study Phase 1/Phase 2
Recruiting NCT01778374 - Mater-Bronx Rapid HIV Testing Project. N/A
Completed NCT00914225 - Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya N/A
Completed NCT01490346 - Tissue Drug Levels of HIV Medications N/A
Completed NCT01460433 - Problems With Immune Recovery in the Gut Tissue N/A
Completed NCT01076179 - Kaletra in Combination With Antiretroviral Agents N/A
Completed NCT00317460 - Buprenorphine and Integrated HIV Care Phase 4
Terminated NCT04240210 - Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) Phase 4
Active, not recruiting NCT04704336 - Integration of Hypertension Management Into HIV Care in Nigeria N/A
Completed NCT03254277 - 3BNC117-LS First-in-Human Phase 1 Study Phase 1